1.0
Feb 25, 2022
Former employee, more than 10 years
Recommend
CEO approval
Business Outlook
Pros
Possible new product launches in the future
Cons
Huge down grade from Pfizer to Viatris in terms of company benefits. And business support tools Poor communication from leadership team